| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |